Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BACLOFEN vs BAMLANIVIMAB\ETESEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BACLOFEN vs BAMLANIVIMAB\ETESEVIMAB: Safety Overview

Metric BACLOFEN BAMLANIVIMAB\ETESEVIMAB
Total FAERS Reports 25,750 830
Deaths Reported 2,958 17
Death Rate 11.5% 2.0%
Hospitalizations 8,773 189
Average Patient Age 46.9 yrs 51.3 yrs
% Female Patients 50.3% 58.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer PD-Rx Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A